PD173955 - CAS# 260415-63-2 Catalog No.:M11371-2 1993 Sep 1

1993 Sep 1

(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Epub 2019 Jul 2

which has antivirus and antitumor ability

PubMed PMID: 19338769

PD173955 - CAS# 260415-63-2 Catalog No.:M11371-2 1993 Sep 1PD 173955 is a src tyrosine kinase inhibitor. PD173955 inhibited Bcr Abl dependent cell growth. PD173955 showed cell cycle arrest in G(1). PD173955 has an IC(50) of 1 2 nM in kinase inhibition assays of Bcr Abl, and in cellular growth assays it inhibits Bcr Abl dependent substrate tyrosine phosphorylation. PD173955 inhibited kit ligand dependent c kit autophosphorylation (IC(50) = approximately 25 nM) and kit ligand dependent proliferation of M07e